Skip to contentpdufa.bio

12-week placebo-controlled

Page updated ·next FDA decision on the calendar ·Data as of Nov 19, 2026 12:24 AM ET

12-week placebo-controlled is a Satellos Bioscience Inc. program. Its next catalyst is a Readout in Q1 2027.

MSLE catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Satellos Bioscience Inc. (MSLE). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Q1 2027MSLE

Questions

When is 12-week placebo-controlled's next FDA decision or readout?

The next tracked catalyst for 12-week placebo-controlled is a Readout in Q1 2027.

What happened at 12-week placebo-controlled's most recent FDA decision?

No FDA decision for 12-week placebo-controlled is in our archive yet.

Who makes 12-week placebo-controlled?

Satellos Bioscience Inc. (MSLE).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings. Each FDA decision links its own page, which names its source or says plainly that it has none.